Shanghai Chest Hospital: all 198 studies
Page 2 of 2. Open to participants first (98), then studies with results posted, then the rest; newest registration first within each.
- Shanghai Clinical Cohort - Esophageal CancerCompletedNCT07312526
- Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）Active, not recruitingNCT07076693Phase 2/3
- Intracardiac Echocardiography-Guided Catheter Ablation for Premature Ventricular Contractions Originating From the Papillary MusclesActive, not recruitingNCT06898281Not applicable
- PerAF: AF Termination vs Prespecified AblationCompletedNCT06837441Not applicable
- Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive AblationCompletedNCT06829446Not applicable
- Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AFCompletedNCT06660134Not applicable
- Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-inferiority TrialCompletedNCT06548451Not applicable
- A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLCActive, not recruitingNCT06443684
- A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial FibrillationCompletedNCT05921734Not applicable
- AF Ablation for HF With Reduced EFCompletedNCT05827172Not applicable
- Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)Active, not recruitingNCT05816499Phase 1/2
- Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC PatientsActive, not recruitingNCT05751187Phase 2
- Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）Status unknownNCT05650216Phase 2
- Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)Active, not recruitingNCT05621707Phase 2
- Electroacupuncture Intervention in Catheter Ablation of Atrial FibrillationStatus unknownNCT05575544Not applicable
- Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLsCompletedNCT05512533Not applicable
- Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial FibrillationStatus unknownNCT05466266Not applicable
- Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD EvaluationStatus unknownNCT05460195Phase 2
- Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial EnlargementCompletedNCT05227586
- SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLCStatus unknownNCT05177497Phase 2
- Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial FibrosisStatus unknownNCT05173779Not applicable
- Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung ResectionStatus unknownNCT05162235Not applicable
- Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial FibrosisStatus unknownNCT05153486Not applicable
- Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter AblationStatus unknownNCT05125042Not applicable
- Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant ChemoradiotherapyStatus unknownNCT05103501Phase 2
- Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.Status unknownNCT05085912Not applicable
- A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC PatientsActive, not recruitingNCT05078931Phase 2
- A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.Status unknownNCT05005468Phase 2
- To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.Active, not recruitingNCT04985851Not applicable
- Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal CancerStatus unknownNCT04984096
- Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC PatientsCompletedNCT04967079Phase 1
- Termination of Persistent Atrial Fibrillation by Catheter AblationStatus unknownNCT04958928
- Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCStatus unknownNCT04895930Phase 2
- Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib TreatmentStatus unknownNCT04882345Phase 2
- Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain MetastasesStatus unknownNCT04870190Phase 3
- To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 FusionStatus unknownNCT04814056Phase 4
- Advanced Lung Tumor Treated by Osimertinib Plus AnlotinibCompletedNCT04770688Phase 1/2
- The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGOStatus unknownNCT04727190Not applicable
- Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung CancerStatus unknownNCT04684017Phase 2
- NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With ImmunotherapyStatus unknownNCT04636047
- Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLCStatus unknownNCT04613284Phase 4
- Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world StudyStatus unknownNCT04597346
- Diagnostic Value of UTB and TB for PPLCompletedNCT04571476Not applicable
- Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLCCompletedNCT04507906Phase 1/2
- Dacomitinib in Lung Cancer With Uncommon EGFR MutationsActive, not recruitingNCT04504071Phase 2
- Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS ImageStatus unknownNCT04497233
- The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.CompletedNCT04489004Not applicable
- Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC PatientsStatus unknownNCT04473703
- cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation OperationStatus unknownNCT04413656Not applicable
- Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLCStatus unknownNCT04405674Phase 2
- Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 InsertionsStatus unknownNCT04382300Phase 2
- Prediction Model of CP-EBUS in the Diagnosis of Lymph NodesStatus unknownNCT04328792
- Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIBStatus unknownNCT04197076
- Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary NodulesStatus unknownNCT04182893
- NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung CancerStatus unknownNCT04159337
- To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive MutationStatus unknownNCT04132102Phase 4
- Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)Status unknownNCT04124731Phase 2
- ENB Guided MWA for Early-stage Peripheral Lung CancerStatus unknownNCT04005157Not applicable
- China Lung Cancer Screening (CLUS) Study Version 2.0Status unknownNCT03975504Not applicable
- Pre-Surgery If Needed for Oesophageal CancerCompletedNCT03937362
- KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03927495Phase 2
- Apatinib in the Treatment of Recurrence or Metastasis of Esophageal CancerStatus unknownNCT03913182Phase 2
- Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung CancerStatus unknownNCT03802266Not applicable
- ENB for the Diagnosis of PPNs:a Real World StudyCompletedNCT03716284
- Non-Invasive ctDNA Methylation Detection for Lung Nodule PatientsStatus unknownNCT03685669
- First-line Combination Treatment Based on AnlotinibStatus unknownNCT03628521Phase 1
- Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATSStatus unknownNCT03599505
- EBUS Image Features in the Diagnosis of PPLsStatus unknownNCT03575715Not applicable
- ENB in the Diagnosis of Peripheral Pulmonary NodulesStatus unknownNCT03569306Not applicable
- A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLCStatus unknownNCT03546452
- EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual ProgressionCompletedNCT03544814Phase 2
- Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLCStatus unknownNCT03331575Phase 3
- Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted TherapyCompletedNCT03309462Not applicable
- Robot-assisted Esophagectomy Versus Conventional Thoracoscopic EsophagectomyStatus unknownNCT03094351Phase 3
- ENB Guided RFA for Early-stage Peripheral Lung CancerStatus unknownNCT03009630Not applicable
- Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLCStatus unknownNCT02990780Phase 3
- To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerStatus unknownNCT02977169Phase 2
- Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung CancerStatus unknownNCT02975609Phase 2
- To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerTerminatedNCT02974426Phase 3
- Transbronchial Ablation for Peripheral Lung TumorStatus unknownNCT02972177Not applicable
- Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled TrialStatus unknownNCT02951637Phase 2
- Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine CarcinomaStatus unknownNCT02943798Phase 2
- Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung CancerStatus unknownNCT02941003Not applicable
- SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver MutationsStatus unknownNCT02940990Phase 2
- 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical StudyStatus unknownNCT02938546Phase 3
- Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal CancerStatus unknownNCT02938195Phase 2
- Precision Diagnosis and Therapy for Early Stage Lung CancerStatus unknownNCT02936804Not applicable
- Catheter Ablation of Longstanding Persistent Atrial FibrillationStatus unknownNCT02929836Not applicable
- Early Stage Lung Cancer Screening With Low-dose Computed TomographicStatus unknownNCT02898441Not applicable
- Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal CancerStatus unknownNCT02891083Phase 3
- Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLCStatus unknownNCT02669719Phase 2
- Percutaneous Cryoablation Peripheral Lung CancerStatus unknownNCT02665390Not applicable
- UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLsCompletedNCT02664259Not applicable
- The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves ReplacementCompletedNCT02644616Phase 4
- Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)Status unknownNCT02338011Phase 2/3
- EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLsStatus unknownNCT01895166Not applicable
- Recombinant BNP on Heart and Renal Function in Acute Heart FailureStatus unknownNCT01625403Phase 2
- Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant ChemotherapyTemporarily not availableNCT01297101